The purpose of this clinical research study is to learn whether subjects treated with aripiprazole are able to abstain from alcohol use for a greater number of days than subjects treated with placebo. The safety of using aripiprazole will also be studied.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
400
Tablets, Oral, 2-30mg, Once daily, 12 weeks.
Tablets, Oral, Once daily, 12 weeks.
Local Institution
Farmington, Connecticut, United States
Local Institution
New Haven, Connecticut, United States
Local Institution
Indianapolis, Indiana, United States
Assessment of abstinence from the consumption of alcohol during the study
Assessment of alcohol use during the study and behavioral measures of substance abuse an dependence
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Local Institution
Boston, Massachusetts, United States
Local Institution
New York, New York, United States
Local Institution
Rochester, New York, United States
Local Institution
Chapel Hill, North Carolina, United States
Local Institution
Philadelphia, Pennsylvania, United States
Local Institution
Providence, Rhode Island, United States
Local Institution
Charleston, South Carolina, United States
...and 4 more locations